New Segment Combines Capabilities that Help Patients Achieve Optimum Health
SOMERSET, N.J., Oct. 1 /PRNewswire-FirstCall/ -- inVentiv Health Inc. (Nasdaq: VTIV) today announced that it has launched a fourth business segment, inVentiv Patient Outcomes, with a focus on helping pharmaceutical companies and healthcare payors achieve the best possible medical outcomes for patients.
"When patients get on and stay on the right therapy, everyone wins - the healthcare providers, the pharmaceutical companies, the employers, the healthcare payors, and of course, the patients themselves. Unfortunately, patients often don't stay on therapy long enough or don't achieve the optimum results due to reasons ranging from poor training and education, to inability to afford the treatment, to lack of physician involvement," said Blane Walter, President of inVentiv Health. "With our new Patient Outcomes division, inVentiv is uniquely positioned to address these challenges through an array of services that support better patient care."
The inVentiv Patient Outcomes segment includes:
* The Therapeutics Institute, which is comprised of approximately 300
nurse educators who can assist physicians and nurses in designing and
implementing in-office patient education;
* Adheris, which helps educate and motivate patients to stay on therapy
by providing pharmacy-based communications programs;
* The Franklin Group, which provides access to medication through
reimbursement case management services and administers patient
assistance programs for those who need financial support to afford
* AWAC, inVentiv's newest acquisition, which provides di
|SOURCE inVentiv Health, Inc.|
Copyright©2007 PR Newswire.
All rights reserved